Logo
x

Search

Subscribe Now

previously

BMS' Revlimid + Rituximab Receives EC's Approval to Treat Adults Previously Treated Follicular Lymphoma (Grade 1-3a)

BMS' Revlimid + Rituximab Receives EC's Approval to Treat Adults Previously Treated Follicular Lymphoma (Grade 1-3a)

  • December 23, 2019
BMS Reports Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) for Patients with Previously Treated Advanced Hepatocellular Carcinoma

BMS Reports Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) for Patients with Previously Treated Advanced Hepatoce...

  • November 12, 2019
AstraZeneca Canada's Calquence (acalabrutinib) Receives Health Canada Approval for Patients Previously Treated with Mantle Cell Lymphoma (MCL)

AstraZeneca Canada's Calquence (acalabrutinib) Receives Health Canada Approval for Patients Previously Treated with Mantle Cell Ly...

  • October 9, 2019
Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma

Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarci...

  • September 27, 2019
Roche Reports Results of Tecentriq in P-III IMvigor130 Study for Previously Untreated Advanced Bladder Cancer

Roche Reports Results of Tecentriq in P-III IMvigor130 Study for Previously Untreated Advanced Bladder Cancer

  • August 5, 2019
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE-TN Trial for Patients with Previously Untreated Chronic Lymphocytic Leukemia

AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE-TN Trial for Patients with Previously Untreated Chronic...

  • June 6, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.